Navigation Links
PDL BioPharma Announces First Quarter 2011 Financial Results
Date:4/27/2011

INCLINE VILLAGE, Nev., April 27, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the first quarter ended March 31, 2011.

Total revenues for the first quarter of 2011 were $83.3 million, compared to $62.1 million for the same period of 2010, and include a one-time settlement payment of $10 million from UCB Pharma resolving all legal disputes between the two companies. Excluding the one-time settlement payment, total revenue increased 18 percent for the first quarter of 2011 when compared to total revenue for the same period of 2010.  

Royalty revenues for the first quarter of 2011 are based on fourth quarter 2010 product sales by PDL's licensees.  Revenue growth for the first quarter of 2011 over the same period in 2010 was primarily driven by increased fourth quarter 2010 sales by the Company's licensees of Herceptin®, which is marketed by Genentech and Roche; Lucentis®, which is marketed by Genentech and Novartis; and Tysabri®, which is marketed by Elan and Biogen Idec. Also contributing to the increased royalty revenue are increased royalties from sales of Avastin® that was both manufactured and sold outside of the United States. PDL received royalties for these product sales in the first quarter of 2011.

Total general and administrative expenses for the first quarter of 2011 were $5.8 million, compared with $9.4 million for the same period of 2010. The decrease in general and administrative expenses was primarily driven by decreases in legal and professional services expenses. The decrease in legal expense is a result of the conclusion of the outstanding legal issues with MedImmune, the opposition to PDL's European patent in the European Patent Office (EPO) and the interference proceedings in the U.S. Patent and Trademark Office (PTO), all of which were resolved i
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Reportlinker Adds Upstream Processing in Biopharmaceuticals - Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
2. Perceptive Informatics Survey Results Reveal Biopharmaceutical Industrys View on Most Important eClinical Attributes
3. Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors
4. Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality
5. Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform
6. Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
7. Genesis Biopharma to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17
8. Tufts Launches Institute for Biopharmaceutical Partnerships
9. Genesis Biopharma Announces Management and Board Changes
10. Keryx Biopharmaceuticals to Present at 13th Annual BIO CEO and Investor Conference
11. Alzheimers Drug Discovery Foundation Funds ALS Biopharma to Develop Small Molecules for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... consumers, are increasingly searching for food alternatives that ... nutritional benefits. The food ingredient market has numerous ... players such as Vital Force Technology (VFT). ... more than 4,000 energetic patterns, all tested to ...
(Date:7/31/2014)... 2014 Nearly 20,000 medical professionals and healthcare ... & Clinical Lab Expo in Chicago ... in diagnostic research and technology that will advance medicine ... As of Wednesday, July 30, more than 19,500 attendees ... Clinical Lab Expo, with more than 10,000 of these ...
(Date:7/31/2014)... ability to see through organs and even the entire ... as fine-grained cellular structures has been a long-time dream ... Press July 31st in the journal Cell ... methods for making opaque organs, bodies, and human tissue ... intact. The protocols could pave the way for a ...
(Date:7/31/2014)... SPRINGS, Colo. , July 31, 2014 /PRNewswire-USNewswire/ ... Grant awardee today with $25,000 to fund a ... Foundation,s inception in 2011, the gift was presented ... th Annual Meeting in Colorado ... who specialize in neurointerventional approaches to neurovascular conditions, ...
Breaking Biology Technology:Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3See-through organs and bodies will accelerate biomedical discoveries 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3
... DirectorFAIRFAX, Va., Feb. 25 Edmond Scientific Company ... our team of Tony Mallia as Practice Director. ... bringing to bear his experience of enterprise integration in ... financial services sectors. The core goal of this methodology ...
... plastic surgeryMEDFORD, Mass., Feb. 25 Serica ... developing silk-based biomaterial platforms for tissue regeneration, ... from the U.S. Food and Drug Administration ... long term bioresorbable scaffold technology."We are delighted ...
... 25 Bio-Matrix Scientific Group,Inc. (OTC Bulletin Board: BMSN) ... created positions on its management team. Feng Lin, M.D., ... Laboratory/Scientific,Director and Marilyn Panahi is serving as Quality Assurance ... and Marilyn Panahi bring tremendous expertise to the,administrative operations ...
Cached Biology Technology:Edmond Scientific Company 'Spotlight on the Executive': 2Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 2Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 3Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 4Bio-Matrix Scientific Group Announces New Hires to Management Team 2
(Date:8/1/2014)... enormous opportunities for both biological and future clinical ... cells in the body, offering immense hope of ... kidney, liver and lung diseases and making damaged ... Prof. Jinhui Chen from Indiana University in USA ... myriad biological, ethical, legal, political, and financial challenges. ...
(Date:8/1/2014)... Colo., USA One of the most diverse families ... as Lucinidae (or lucinids) -- originated more than 400 ... and life habits like those of its modern members. ... the University of Hawaii, published online on 25 July ... through significant symbiotic relationships. , At is origin, the ...
(Date:8/1/2014)... -- LiveScan Service Provider Binary Biometrics is pleased to welcome Kevin ... will improve its mobile service capabilities and add more daily appointments, which will ... service several new cities such as, but not limited to, Daytona ... Deltona , Edgewater , Holly ... Beach , Oak Hill , Orange City ...
Breaking Biology News(10 mins):Symbiotic survival 2Symbiotic survival 3Symbiotic survival 4Symbiotic survival 5Symbiotic survival 6Symbiotic survival 7Symbiotic survival 8Symbiotic survival 9Symbiotic survival 10Symbiotic survival 11Symbiotic survival 12Symbiotic survival 13Symbiotic survival 14Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 2Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 3
... great at protecting leaves from being chomped by slugs, suggests ... . Although they lurk in the soil, they seem to ... the amount of damage slugs do to individual plants. ... 100 worst alien species in Europe and are considered a ...
... more than 13,000 men identified four new genetic variants ... most commonly diagnosed type in young men today. The ... 12 in Nature Genetics by researchers at ... of Pennsylvania . The discovery of these genetic ...
... anomalous pulmonary venous connection (TAPVC), one type of "blue ... occurs when pulmonary veins don,t connect normally to the ... oxygenated blood throughout the body, and TAPVC babies are ... , TAPVC is usually detected in newborns when babies ...
Cached Biology News:Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer 2Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer 3Mutation causing wrong-way plumbing explains 1 type of blue-baby syndrome 2
Certified U.S. origin. Bovine Serum:, *Certified U.S. origin. Available raw, nonsterile filtered, or sterile filtered. , , *Sterility tested , , *Low Hemoglobin levels , , *Mycoplasma testing upon...
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
... contains 4 deuterium atoms at the 9, 10, ... use as an internal standard for the quantification ... is produced by the lipoxygenation of linoleic acid ... detected in atherosclerotic plaques, as an esterified component ...
Biology Products: